EP3698796
PHARMACEUTICAL COMBINATION OF A TRICYCLIC BETA-LACTAMASE INHIBITOR WITH SPECIFIC BETA-LACTAM ANTIBIOTICS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.9.2017EP published:
27.10.2021EP application number:
20165564.4
EPO information:
European Patent Register
Max expiry date:
27.9.2037
Title:
PHARMACEUTICAL COMBINATION OF A TRICYCLIC BETA-LACTAMASE INHIBITOR WITH SPECIFIC BETA-LACTAM ANTIBIOTICS
Timeline
Today
28.9.2017EP application
27.10.2021EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
CASAREZ, AnthonyAddress:
Emeryville, CA 94608, US
Name:
FUREGATI, MarkusAddress:
4002 Basel, CH
Name:
KOCH, GuidoAddress:
4002 Basel, CH
Name:
LIN, XiaodongAddress:
Emeryville, CA 94608, US
Name:
OSSOLA, FlavioAddress:
4002 Basel, CH
Name:
RECK, FolkertAddress:
Emeryville, CA 94608, US
Name:
SIMMONS, Robert LowellAddress:
Emeryville, CA C94608, US
Name:
ZHU, QingmingAddress:
Emeryville, CA 94608, US
Priority
Number:
201662401022 PDate:
28.9.2016Country:
US
Classification
Categories:
C07D 471/18, A61K 31/407, A61P 31/04, A61K 31/427, A61K 31/431, A61K 31/496, A61K 31/546, A61K 31/551, A61K 45/06